# Donepezil

## Aricept 5mg

#### 限交付調劑

| 藥品代碼       | OARI                                  |
|:---------------|:--------------------------------------|
| 適應症         | Mild to moderate Alzheimer's disease. |
| 用法用量       | 1 tab daily.                          |
| 肝功能異常     | 無需調整劑量                          |
| 腎功能異常     | 無需調整劑量                          |
| 禁忌           | nan                                   |
| 副作用         | nan                                   |
| 孕期用藥建議   | nan                                   |
| 哺乳期用藥建議 | nan                                   |

## Aricept 10mg orodispersible

#### 一般可用

| 藥品代碼       | OARIE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:---------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Treatment of mild to moderate dementia of the Alzheimer's type.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 用法用量       | Initial， 5 mg orally once daily at bedtime; if suboptimal clinical response， may titrate to 10 mg orally once daily at 4 to 6 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 禁忌           | Patients with a known hypersensitivity to donepezil HCl， piperidine derivatives or to any excipients used in Aricept. Use in children: Aricept is not recommended for use in children.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 副作用         | Nausea， diarrhea， insomnia， vomiting， muscle cramp， fatigue & anorexia. Syncopal episodes have been reported. Cardiovascular: Hypertension (3% )， Syncope (2% ) Endocrine metabolic: Weight decreased (3% to 5% ) Gastrointestinal: Diarrhea (5% to 15% )， Loss of appetite (2% to 8% )， Nausea (3% to 19% )， Vomiting (3% to 9% ) Hematologic: Contusion (2% )， Ecchymosis (4% to 5% ) Musculoskeletal: Cramp (3% to 8% )， Increased creatine kinase level (3% ) Neurologic: Asthenia (1% to 2% )， Dizziness (2% to 8% )， Headache (3% to 4% )， Insomnia (2% to 14% )， Somnolence (1% to 2% ) Psychiatric: Depression (2% to 3% )， Dream disorder (3% ) Renal: Urinary incontinence (1% to 3% ) Other: Fatigue (1% to 8% ) |
| 孕期用藥建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 哺乳期用藥建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

